Digital therapeutics company Akili said the FDA cleared its EndeavorOTC digital therapeutic treatment for adults with attention-deficit/hyperactivity disorder (ADHD). EndeavorOTC is indicated to improve attention function as measured by computer-based...
The post FDA Clears Akili’s EndeavorOTC Digital Treatment For Adults With ADHD appeared first on OPEN MINDS.